Scientific News
2005
Santhera Starts European Phase III Study with Its Lead Compound SNT-MC17 (idebenone) in Friedreich’s Ataxia
December 15, 2005
Santhera and the NIH Collaborate to Evaluate SNT-MC17 in Friedreich’s Ataxia
November 3, 2005
NINDS Recruiting Patients for Phase 2 Idebenone Study
September 28, 2005